John W. Park

Pure CTCs, advanced WGS, and precise personalized combination therapies

Radoje Drmanac, Brock A. Peters, John W. Park, 2017, Oncoscience.

Development of anti-p185HER2 immunoliposomes for cancer therapy.

John W. Park, H. Asgari, P. Carter, 1995, Proceedings of the National Academy of Sciences of the United States of America.

In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an 125I-labelled DNA-intercalator

John W. Park, K. Edwards, L. Gedda, 2011, Journal of drug targeting.

Immunoliposomes for cancer treatment.

John W. Park, C. Benz, D. Kirpotin, 1997, Advances in pharmacology.

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

John W. Park, C. Benz, P. Carter, 1997, Biochemistry.